Inventor · disambiguated record
Anish Suri
Also filed as: SURI ANISH
11 granted patents·21 pending applications·84 citations·filing 2012–2025
89Inventor score
Top patents by PatentIndex Score
32 records- 0194US8895010B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 25, 2014·24 cites·36 claims
- 0291US9475879B2Antibody polypeptides that antagonize CD40SURI ANISH·Filed 2012·Granted Oct 25, 2016·31 cites·15 claims
- 0391US9228018B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·11 cites·35 claims
- 0488US9765150B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 19, 2017·5 cites·37 claims
- 0588US8981072B2Nucleic acids encoding antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 17, 2015·8 cites·27 claims
- 0684US10669343B2Anti-CD154 antibodies and methods of using themJANSSEN BIOTECH INC·Filed 2016·Granted Jun 2, 2020·3 cites·66 claims
- 0778US10196451B2Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40LBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 0878US2022073636A1Antibody polypeptides that antagonize cd40lBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0973US10544228B2Nucleic acids encoding antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 1072US2024317815A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1171US11180567B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
- 1269US2025041404A1T Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1368US2025026807A1Immune Cell Binding PolypeptidesCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1468US2025041419A1Modified Cytotoxic T Cells and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1566US2023055644A1T-cell modulatory chimeric molecules and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1666US2023000914A1Modified cytotoxic t cells and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1766US2025041396A1T Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1865US2025019411A1T-Cell Engaging Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1965US2025376491A1T-Cell Modulatory Multimeric Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 2064US11136406B2Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 2163US2025161355A1Proteins for modulating cell therapy products and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2261US2023338509A1T cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2361US2024034770A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2459US11421037B2Nucleic acids encoding anti-CD154 antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Aug 23, 2022·0 cites·25 claims
- 2558US2023416321A1TGF-Beta PolypeptidesCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2657US2024082411A1T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2757US2020231676A1Methods of treating transplant rejection using a domain antibody directed against cd40lBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2855US2022017596A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2954US2023117521A1T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3054US2023279076A1T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 3149US2017051059A1Methods of treating transplant rejection using a domain antibody directed against cd40BRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3248US2025243254A1Interleukin-2 Polypeptides, Fusion Polypeptides, and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anish Suri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →